Work

Pd42-11 Development and Validation of a Multimodal Artificial Intelligence (mmai)-derived Digital Pathology-based Biomarker Predicting Metastasis for Radical Prostatectomy Patients With Biochemical Recurrence in Nrg/rtog Trials